Global Plasma Therapy Market Growth (Status and Outlook) 2025-2031

Global Plasma Therapy Market Growth (Status and Outlook) 2025-2031

The global Plasma Therapy market size is predicted to grow from US$ 321 million in 2025 to US$ 580 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.

LPI (LP Information)' newest research report, the “Plasma Therapy Industry Forecast” looks at past sales and reviews total world Plasma Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Plasma Therapy sales for 2025 through 2031. With Plasma Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Therapy industry.

This Insight Report provides a comprehensive analysis of the global Plasma Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Plasma Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasma Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)

Segmentation by Application:
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics